The Hepatitis B Foundation announced on Thursday that Robert G. Gish was named the nonprofit foundation's medical director on Jan. 30.
The foundation said Gish has made invaluable contributions to understanding and the treatment of hepatitis B, which is the leading cause of liver cancer. The new role will strengthen Gish's position as a longtime supporter and member of the Scientific Advisory Board, as well as his research and advocacy work around the world.
"We are delighted to welcome Dr. Gish to our board," W. Thomas London, the senior member emeritus of Fox Chase Cancer Center and vice president of the board of directors of the Hepatitis B Foundation, said. "He has long been a leader in the field and has extensive experience in the conduct of clinical trials of new drugs to combat chronic hepatitis B. His leadership as medical director will help us advance the treatment and prevent the severe consequences of this potentially deadly disease."
Gish has continued researching and investigating viral hepatitis B since receiving his medical degree in 1980. He was the medical director of the liver transplant program at California Pacific Medical Center, and developed an outreach program that served more than 35,000 patients in California and Nevada.
"Dr. Gish's background is a perfect fit for the work we do here at the Foundation and our Baruch S. Blumberg Institute," Timothy Block, the president of the Hepatitis B Foundation and a professor of Microbiology at Drexel University, said. "We are honored that Dr. Gish has agreed to become our medical director and look forward to many years of collaboration so we can finally put an end to this serious liver infection."
Gish has published more than 600 articles, abstracts and book chapters, in addition to more than 120 peer-reviewed publications, during his career. He is currently a clinical professor of medicine at the University of Nevada, located in Las Vegas, and a senior consultant at St. Joseph's Medical Center in Phoenix. Gish formed a consulting firm in 2013 to support liver health and transplant programs with operations, outreach, compliance, financial planning and program development.